FRESENIUS MEDICAL CARE AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.46 EUR | -0.10% |
|
-5.54% | -3.87% |
| Jun. 19 | FMC FRESENIUS MEDICAL CARE AG & CO KGAA : UBS sticks Neutral | ZD |
| Jun. 14 | FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies | ZD |
| Sales 2024 * | 19.56B 20.96B | Sales 2025 * | 20.3B 21.76B | Capitalization | 10.71B 11.48B |
|---|---|---|---|---|---|
| Net income 2024 * | 665M 713M | Net income 2025 * | 964M 1.03B | EV / Sales 2024 * | 1.05 x |
| Net Debt 2024 * | 9.86B 10.57B | Net Debt 2025 * | 8.99B 9.63B | EV / Sales 2025 * | 0.97 x |
| P/E ratio 2024 * |
16.1
x | P/E ratio 2025 * |
11.1
x | Employees | 117,128 |
| Yield 2024 * |
2.9% | Yield 2025 * |
3.59% | Free-Float | 67.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Fresenius Medical Care AG
More recommendations
More press releases
More news
| 1 day | -0.04% | ||
| 1 week | -5.68% | ||
| Current month | -6.84% | ||
| 1 month | -9.85% | ||
| 3 months | +1.84% | ||
| 6 months | -3.69% | ||
| Current year | -3.85% |
1 week
35.80
38.75
1 month
35.8041.46
Current year
33.8842.12
1 year
30.1649.62
3 years
25.9571.14
5 years
25.9581.10
10 years
25.9593.82
| Managers | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 56 | 19-10-31 |
Martin Fischer
DFI | Director of Finance/CFO | 47 | 23-09-30 |
Franklin Maddux
CTO | Chief Tech/Sci/R&D Officer | 65 | 08-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 16-05-11 |
Shervin Korangy
BRD | Director/Board Member | 50 | 23-07-13 |
Marcus Kuhnert
BRD | Director/Board Member | 56 | 23-07-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.48% | 202 M€ | -.--% | ||
| 1.12% | 2 M€ | +13.56% | - | |
| 0.80% | 79 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-21 | 36.49 | -0.03% | 153 163 |
| 24-06-20 | 36.5 | +0.66% | 313,750 |
| 24-06-19 | 36.26 | -1.12% | 340,659 |
| 24-06-18 | 36.67 | -1.37% | 497,948 |
| 24-06-17 | 37.18 | -3.75% | 453,771 |
Delayed Quote Xetra, June 20, 2024 at 11:42 am EDT
More quotes
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
2024-07-29
- Q2 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.5
EUR
Average target price
39.97
EUR
Spread / Average Target
+9.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.85% | 11.48B | |
| +25.01% | 88.62B | |
| -22.75% | 76.58B | |
| +3.24% | 26.87B | |
| -8.76% | 17.48B | |
| +1.00% | 17.11B | |
| +0.23% | 15.35B | |
| +78.95% | 13.21B | |
| +71.14% | 13.16B | |
| -25.61% | 12.98B |
- Stock Market
- Equities
- FME Stock
